Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-09-26
1993-07-06
Shah, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514105, C07D26536, C07D11302, A61K 31535
Patent
active
052254097
ABSTRACT:
Benzoxazinone compounds of general formula (I): ##STR1## useful in the treatment of serotoninergic disorders, especially anxiety and schizophrenia, requiring for their treatment compounds which are 5-HT.sub.1A receptor agonists, wherein R.sub.1, R.sub.2, R.sub.3, and n are as defined in the description, and medicinal products containing the same, are disclosed.
REFERENCES:
patent: 3770734 (1973-11-01), Pesson
Goodman & Gilman's "The Pharmacological Basis of Therapeutics", 8th Edition, 1990 (Pergamon Press), p. 44.
Journal of Pharmacological Methods, 13, 193-200, (1985), 193-200, Martin.
Adam Gerard
Caignard Daniel H.
Depreux Patrick
Guardiola Beatrice
Lesieur Isabelle
Adir et Compagnie
Datlow Philip I.
Hueschen Gordon W.
Shah Raymond J.
LandOfFree
Benzoxazinone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoxazinone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazinone compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1689699